March 8, 2006

Pharma Takes Custom App Development Offshore

by Laura Ramos

with Bradford J. Holmes, Stephanie Moore, Julie Snyder, Alyssa L. Baer

Executive Summary (This is a document excerpt)

While pharma companies currently send many of the same IT activities, like software maintenance and desk support, offshore as other industries, Forrester's Business Technographics data shows that within the next 12 months, drug firms plan to increase the amount of custom app development done abroad. Pharma firms are feeling the dual pressure to satisfy the complex and costly demands of scientific discovery while keeping margin-focused stockholders happy. The fix? Pharma executives should step up their evaluation of offshore partners, particularly those in geographic proximity to their own global operations, to outsource IT-specific activities.

Buy Risk-Free

Download and print PDF immediately. Price: US $499

Our Money-Back Guarantee: If you are not completely satisfied, return it for a full refund within three weeks of your online purchase.

Already a Forrester Client?
Log in to read this document.